NASDAQ · Medical - Care Facilities

TALK (TALK) Stock

$5.22 +0.19% NASDAQ: TALK Healthcare

Valuation

MetricValue
Price$5.22
Market Cap$874.42M
P/E Ratio129.75
P/B Ratio7.42
P/S Ratio3.65
EPS (TTM)$0.04
52-Week High$5.24
52-Week Low$2.22
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE6.84%
ROA5.93%
ROCE2.56%
Gross Margin1.31%
Operating Margin1.31%
Net Margin0.49%
Debt/Equity0.00
Current Ratio6.53

Annual Financials (USD)

Metric20212022202320242025
Revenue$114.0M$120.0M$150.0M$188.0M$229.0M
Operating Profit$-94.0M$-77.0M$-23.0M$-4.0M$3.0M
Net Profit$-63.0M$-80.0M$-19.0M$1.0M$8.0M
EPS$-0.72$-0.51$-0.12$0.01$0.04
Op Margin-82.6%-64.4%-15.5%-2.4%1.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$224.0M$156.0M$142.0M$139.0M$135.0M
Total Liabilities$31.0M$29.0M$24.0M$21.0M$18.0M
Cash$198.0M$139.0M$124.0M$77.0M$37.0M
Borrowings$0$1.0M$0$0$0

Latest News

Traditional AI chatbots were 'never developed' for therapy: Talkspace CEO Yahoo Finance Video · Jul 8, 2026 Chatbots Are Replacing Therapists With Little Scientific Evidence Behind Them The Wall Street Journal · Jun 30, 2026 Talkspace Announces ‘Tee,’ the First Safe AI Agent Specifically Developed to Help Individuals Navigate Life’s Daily Mental Health Challenges Business Wire · Jun 9, 2026 Talkspace Shareholders Approve Acquisition by Universal Health Services MT Newswires · May 29, 2026 Talkspace Stockholders Vote to Approve Acquisition by UHS GlobeNewswire · May 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-66.0M$-61.0M$-16.0M$12.0M$9.0M
Investing Cash Flow$-1.0M$-1.0M$0$-52.0M$-40.0M
Financing Cash Flow$0$-1.0M$-1.0M$-12.0M$-20.0M
Net Cash Flow$185.0M$-60.0M$-15.0M$-47.0M$-39.0M
Free Cash Flow$-66.0M$-61.0M$-17.0M$6.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA138.59
FCF Yield-0.75%
Quick Ratio4.84
Interest Coverage
Return 1Y98.85%
Return 3Y307.03%
Return 5Y-10.15%

Ownership

Insiders Held5.12%
Institutions Held82.92%
Institutions Float Held87.39%
Institutional HolderSharesReport Date
Hudson Executive Capital, LP11,340,6002026-03-31
Blackrock Inc.10,406,6592026-03-31
Balyasny Asset Management LP8,866,7272026-03-31
Deutsche Bank AG7,121,2402026-03-31
FIL LTD6,683,0402026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AIRS $4.36 -6.55% -26.47 $307.23M 0.00%
AVNS $24.99 +0.04% 19.96 $1.17B 0.00%
CLPT $14.14 -2.68% -13.09 $424.05M 0.00%
CMPSCOMPASS Pathways plc $13.31 -0.60% -6.19 $1.28B 0.00%
CYHCommunity Health Systems, Inc. $2.70 -1.10% -1.21 $380.48M 0.00%

About TALK

TALK is led by CEO Jon R. Cohen, employs 521 people, headquartered in US, publicly traded since 2020.

TALK stock trades at $5.22 with a market capitalization of $874.42M. The stock is valued at a price-to-earnings (P/E) ratio of 129.75, price-to-book of 7.42, price-to-sales of 3.65. Over the past 52 weeks the stock has ranged between $2.22 and $5.24, and currently trades at its 52-week high.

On profitability, TALK generates a return on equity (ROE) of 6.84%, return on capital employed of 2.56%, an operating margin of 1.31%, a net profit margin of 0.49%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides